HEPSIN inhibits cell growth/invasion in prostate cancer cells

Cancer Research

Volumn 62, Issue 23, 2002, Pages 6812-6816

  Srikantan, Vasantha ^a   Valladares, Michael ^a   Rhim, Johng S ^a   Moul, Judd W ^a,b   Srivastava, Shiv ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN HEPSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE G2 PHASE; CELL INVASION; CELL POPULATION; COLONY FORMATION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA;

3T3 CELLS; ANIMALS; CELL DIVISION; G2 PHASE; HUMANS; MALE; MICE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; SERINE ENDOPEPTIDASES; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0036894486     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jemel, A., Thomas, A., Murray, T., and Thun, M. Cancer statistics. CA Cancer J. Clin. 52: 23-47,. 2002.
2. Scher, H., and Heller, G. Clinical states in prostate cancer toward a dynamic model of disease progression. Urology, 55: 323-327, 2000.
3. Garnick, M. B. The dilemmas of prostate cancer. Sci. Am., 270: 72-81, 1994.
4. Brawer, M. K. Prostate-specific antigen. Semin. Surg. Oncol., 18: 3-9, 2000.
5. Moul, J. W., Merseburger, A. S., and Srivastava, S. Molecular markers in prostate cancer: The role in preoperative staging. Clin. Prostate Cancer, 1: 42-50. 2002.
6. Issacs, W. B., and Bova, G. S. Prostate cancer. In: B. Vogelstein and K. W. Kinzler (eds.), The Genetic Basis of Human Cancer, pp. 653-660. Columbus. OH: McGraw-Hill Companies, Inc., 1998.
7. Gelmann, E. P. Molecular biology of the androgen receptor. J. Clin. Oncol., 20: 3001-3015, 2002.
8. Srikantan, V., and Srivastava, S. Prostate cancer. In: R. Hoffmann, A. Heidenreich, and J. W. Moul (eds.), Molecular Dissection of the Prostate Cancer Genome, pp. 25-40. New York, NY: Springer-Verlag GmbH and Co., 2002.
9. Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Issacs, W. B., and Nelson, W. G. Cytidine methylation of regulatory sequences near the π-class glulathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA, 91: 11733-11737, 1994.
10. Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., and Chinnalyan, A. M. Delineation of prognostic biomarkers in prostate cancer. Nature (Lond.), 412: 822-826, 2001.
11. Rubin, M. A,. Zhou, M., Dhanasekaran, S. M., Varambally, S., Barrette, T. R., Sanda, M. G., Pienta, K., Ghosh, D., and Chinnalyan, A. M. α-Methylacyl coenzme A racemase as a tissue biomarker for prostate cancer. J. Am. Med. Assoc., 287: 1662-1670, 2002.
12. Luo, J., Zha, S., Gage, W. R., Dunn, T. A., Hicks, J. L., Bennett, C. J., Ewing, C. M., Platz, E. A., Ferdinandusse, S., Wanders, R. J., Trent, J. M., Issacs, W. B., and De Marzo, A. M. α-Methylacyl coenzme A racemase: A new molecular marker for prostate cancer. Cancer Res., 62: 2220-2226, 2002.
13. Ernst, T., Hergenhahn, M., Kenzelmann, M., Cohen, C. D., Bonrouhi, M., Weninger, A., Klaren, R., Grone, E. F., Wiesel, M., Gudemann, C., Kuster, J., Schott, W., Staehler, G., Kretzler, M., Hollstein, M., and Grone, H. J., Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma. Am. J. Pathol., 160: 2169-2180, 2002.
14. Luo, J., Duggan, D. J., Chen, Y., Sauvageot, J., Ewing, C. M., Bittner, M. L., Trent, J. M., and Issacs, W. B. Human prostate cancer and benign prostatic hyperplasia. Cancer Res., 61: 4683-4688, 2001.
15. Magee, J. A., Araki, T., Patil, S., Ehirg, T., Tree, L., Humphrey, P. A., Catalona, W. J., Watson, M. A., and Milbrandt, J. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res. 61: 5692-5696. 2001.
16. Stamey, T. A., Warrington, J. A., Caldwell, M. C., Chen, Z., Fan, Z., Mahadevappa, M., McNeal, J. E., Nolley, R., and Zhang, Z. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. J. Urol., 166: 2171-2177, 2001.
17. Neil, G. W., and Kelsell, D. P. Spotting prostate cancer. Trends Mol. Med., 7: 432-433, 2001.
18. Zacharski, L. R., Ornstein, D. L., Memoli, V. A., Rousseau, S. M., and Kisiel, W. Expression of the factor VII activating protease, hepsin, in situ in renal cell carcinoma. Thromb. Haemostasis, 79: 876-877, 1998.
19. Tanimoto, H., Yan, Y., Clarke, J., Korourian, S., Shigemasa, K., Pannley, T. H., Parham. G. P., and O'Brien, T. J. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res., 57: 2884-2887, 1997.
20. Leytus, S. P., Loeb, K. R., Hagen, F. S., Kurachi, K., and Davie, E. W. A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry, 27: 1067-1074, 1988.
21. Tsujui, A., Torres-Rosado, A., Arai, T., LeBeau, M. M., Lemons, R. S., Chou, S. H., and Kurachi, K. Hepsin, a cell membrane-associated protease. J. Biol. Chem., 266: 16948-16953, 1991.
22. Torres-Rosado, A., O'Shea, K. S., Tsuji, A., Chou, S. H., and Kurach, K. Hepsin, a putative cell-surface serine protease, is required for mammalian cell growth, Proc. Natl. Acad. Sci. USA, 90: 7181-7185, 1993.
23. Lee, M. S., Garkvenko, E., Yun, J. S., Weijerman, P. C., Peel, D. M., Chen, L. S., and Rhim, J. S. Characterization of adult human prostatic epithelial cells immortalized by polybrene induced DNA transfection with plasmid containing an origin defective SV40 genome. Int. J. Oncol., 4: 821-830, 1994.
24. Nakamura, K., Yasunaga, Y., Ko, D., Xu, L. L., Moul, J. W., Peel, D. M., Srivastava, S., and Rhim, J. S. Cadmium-induced neoplastic transformation of human prostate epithelial cells. Int. J. Oncol., 20: 543-547, 2002.
25. Kuettel, M. R., Thraves, P., Jung, M., Varghese, S. P., Prasad, S. C., Rhim, J. S., and Dritschilo, A. Radiation-induced neoplastic transformation of human prostate epithelial cells. Cancer Res., 56: 5-10. 1996.
26. Rhim, J. S., Weber, M. M., Bellow, D., Lee, M. S., Amstein, P., Chen, L. S., and Jay, G. Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-ki-ras. Proc. Natl. Acad. Sci. USA, 91: 11874-11878, 1994.
27. Rhim, J. S., Jin, S., Jung, M., Thraves, P., Kuettel, M. R., Weber, M. M., and Hukku, B. Malignant transformation of human prostate epithelial cells by N-nitroso-N-methylurea. Cancer Res., 57: 576-580, 1997.
28. Del Rosso, M., Fibbi, G., Pucci, M., D'Alessio, S., Del Rosso, A., Magnell, L., and Chiarugi, V. Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin. Exp. Metastasis. 19: 193-207, 2002.
29. Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang-Rodriguez, J., Moskaluk, C. A., Frierson, H. F., Jr., and Hampton, G. M. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res., 61: 5974-5978, 2001.
30. Kazama, Y., Hamamoto, T., Foster, D. C., and Kisiel, W. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J. Biol. Chem., 270; 66-72, 1995.
31. Wu, Q., Yu, D., Post, J., Halk-Miller, M., Sadler, J. E., and Morser, J. Generation and characterization of mice deficient in hepsin, a hepatic transmembrane serine protease. J. Clin. Investig., 101: 321-326, 1998.
32. Yu, I. S., Chen, H. J., Lee, Y, S., Huang, P. H., Lin, S. R., Tsai, T. W., and Lin, S. W. Mice deficient in hepsin, a serine protease, exhibit normal embryogenesis and unchanged hepatocyte regeneration. Thromb. Haemostasis, 84: 865-870, 2000.
33. Wu, Q. Gene targeting in hemostasis. Hepsin. Front. Bio. Sci., 6: 192-200. 2001.
34. Chen, L. M., Byron Hodge, G., Guarda, L. A., Welch, J. L., Greenberg, N. M., and Chai, K. X. Down-regulation of prostasin serine protease: A potential invasion suppressor in prostate cancer. Prostate. 48: 93-103, 2001.